TrialClinical pharmacology in drug development2020

A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men.

Kei Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.